e. coli strain e1392-75-2a

Cell therapyexperimental

Clinical trial activity

3 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Sep 1, 2015 (NCT02541695)

Timeline

No events for the selected filters.

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • e. coli strain e1392-75-2a

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03596827N/ASep 26, 2018FrieslandCampina, NIZO Food Research
NCT03301103N/ADec 7, 2017NIZO Food Research, PanTheryx, Inc.
NCT02541695N/ASep 1, 2015NIZO Food Research
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
NIZO Food ResearchFor profit3312015
FrieslandCampinaFor profit1012018
PanTheryx, Inc.For profit1012017
3 organizations
Page 1 / 1